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ABSTRACT 
Sleep Patterns and Associated Factors in Children and Adolescents with  
Inflammatory Bowel Disease  
Margo M. Szabo, M.S. 
Youth with inflammatory bowel disease (IBD) may be at increased risk for sleep difficulties due to 
the inflammatory nature of their disease. Moreover, previous research has demonstrated that 
children and adolescents with IBD experience impairment across a variety of psychosocial 
domains. However, the current literature has yet to examine the complex interplay between sleep, 
disease-related symptoms, and psychosocial factors such as mood and health-related quality of life 
in youth with both types of IBD (i.e., Crohn’s disease and ulcerative colitis). Therefore, the 
purpose of this study was to examine sleep patterns and associated factors, including pain, disease 
activity, mood, and health-related quality of life, in children and adolescents with Crohn’s disease 
or ulcerative colitis. A sample of 25 children and adolescents with IBD (Mage = 14.25; range = 10-
18 years; 56% male) and their caregivers were recruited from a pediatric gastroenterology clinic in 
West Virginia. Results indicated no significant association for sleep with abdominal pain, negative 
affect, or positive affect. However, significant associations were revealed among sleep and patient 
age, disease activity, and health-related quality of life. Youth with IBD also demonstrated greater 
sleep disturbance than previously published data using normatively developing samples. Findings 
of the current study suggest that children and adolescents with IBD experience significant sleep 
disturbance, which may impact their disease activity and psychosocial functioning. Consequently, 
healthcare providers should screen for and address sleep difficulties to optimize better outcomes in 
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Sleep Patterns and Associated Factors in Children and Adolescents with 
Inflammatory Bowel Disease  
Inflammatory Bowel Disease (IBD) is a group of chronic medical conditions that are 
characterized by an abnormal immune response and gastrointestinal inflammation (Centers for 
Disease Control and Prevention [CDC], 2014). In addition, IBD is marked by periods of disease 
activity (i.e., symptom flare-ups) and remission, which are unpredictable in nature (Banez, & 
Cunningham, 2009). The CDC (2014) currently estimates that 1.4 million individuals in the United 
States are living with IBD, of which approximately 10% are children under the age of 18. IBD is 
more common in Caucasian individuals than other ethnic groups and is equally prevalent in males 
and females (Crohn’s & Colitis Foundation of America [CCFA], 2014). A recent review indicated 
a global trend towards increasing incidence of IBD among children and adolescents (Benchimol et 
al., 2011). Although the specific cause of IBD is currently unknown, research suggests genetic 
factors and immune response to environmental triggers may be involved in the etiology of IBD 
(Kim & Ferry, 2004).   
Individuals with IBD are diagnosed with one of two disorders, Crohn’s disease (CD) or 
ulcerative colitis (UC). Symptoms of both disorders are separated into three categories including 
gastrointestinal (e.g., diarrhea, abdominal cramping and pain, rectal bleeding, and constipation), 
systematic (e.g., growth failure, weight loss, fever), and endocrine (e.g., delayed puberty, 
osteoporosis) (Kim & Ferry, 2004). Despite the similar symptoms associated with intestinal 
inflammation, there are aspects that differentiate UC and CD. In UC, inflammation is restricted to 
the colon and the top layers of the bowel, while inflammation may occur at part of the 
gastrointestinal tract from the mouth to the anus and may impact all layers of the bowel in CD 
(CDC, 2014). 
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Given the similarity in symptomatology and underlying issue of intestinal inflammation, 
UC and CD have similar treatment regimens. Medications designed to reduce inflammation and 
frequency of symptom flare-ups in UC and CD include aminosalicylates, immunomodulators, 
corticosteroids, anti-tumor necrosis factor (TNF) agents, and antibiotics (CDC, 2014). The CCFA 
(2014) currently recommends aminosalicylates to treat mild to moderate disease, corticosteroids 
and anti-TNF agents to treat moderate to severe disease, and immunomodulators to be used for 
individuals that have not had success with other medications. However, corticosteroids are not 
recommended as long-term maintenance medication for IBD given their side effects (e.g., weight 
gain, osteoporosis, sleep disturbance) (Buchman, 2001). In addition, antibiotics can be used to treat 
infections (CCFA, 2014). Given the nutritional issues present in IBD, patients must maintain a 
healthy, well-balanced diet in which they avoid foods that trigger gastrointestinal symptoms (e.g., 
high-fiber and spicy foods) and may require enteral therapy if they experience chronic malnutrition 
(CCFA, 2014; Kim & Ferry, 2004). Finally, patients with IBD may require surgery if medications 
do not successfully treat symptoms or if complications, such as intestinal blockages, occur (CDC, 
2014). Although surgery cures UC by removing the entire colon, patients must have additional 
procedures done to create either external or internal pouches to empty waste materials into (CCFA, 
2014). In terms of CD, surgery involves the removal of a portion of the bowel, but does not cure 
the disease (CCFA, 2014). Thus, patients with CD often have disease recurrences after surgery.  
The increasing incidence and issues unique to pediatric IBD, such as embarrassment and 
intrusiveness of intestinal symptoms (Banez, & Cunningham, 2009), have generated interest in the 
psychosocial functioning of these youth. Therefore, several studies have examined various aspects 
of psychosocial functioning, including rates of depression and anxiety, school and social 
functioning, family functioning, and health-related quality of life (Greenley et al., 2010; Mackner 
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et al., 2013). However, few studies have addressed sleep problems in this population, despite 
reports implicating circadian rhythm in gastrointestinal diseases (Hoogerwerf, 2009). Moreover, 
those studies that have assessed sleep problems in pediatric IBD have not examined associations 
between sleep and the aforementioned psychosocial factors.  
Sleep 
Sleep has been implicated in various areas of physical health, including growth and 
development, immune functioning, and endocrine function (Bryant, Trinder, & Curtis, 2004; 
Meltzer & Mindell, 2009). Although sleep is vital to health, sleep problems are common among 
children with chronic medical conditions (Palermo & Owens, 2008). Specifically, research has 
demonstrated that children with chronic illnesses may experience frequent night awakenings, 
problems falling asleep, poor sleep quality, decreased sleep duration, disrupted sleep architecture, 
and other sleep disturbances, including sleep-disordered breathing (Lewandowski, Ward, & 
Palermo, 2011). Moreover, disturbed sleep can be associated with a host of daytime sequelae, 
including fatigue and sleepiness, impaired cognitive and academic functioning, and poor socio-
emotional functioning (Fallone, Owens, & Deane, 2002; Meltzer & Mindell, 2009; Wolfson & 
Carskadon, 2003). Because children with chronic illness are already at risk for some of the 
aforementioned problems such as psychosocial distress (Barlow & Ellard, 2006), it is essential to 
examine sleep disturbances within this population.  
Despite the increasing interest in examining sleep disturbances in chronic medical 
conditions, little research has examined this topic in pediatric IBD. However, recent reports have 
suggested sleep and circadian rhythms may influence the gastrointestinal system (Swanson, 
Burgess, & Keskavazian, 2011). More specifically, Swanson and colleagues explained that sleep 
disruption may affect immune functioning, leading to release of inflammatory proteins (e.g.,      
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TNF-α) and potentially impacting inflammation of the gastrointestinal tract. In turn, inflammatory 
responses have been linked to disturbed sleep among a number of chronic inflammatory 
conditions, such as IBD (Ranjbaran et al., 2007b). Given that IBD is characterized by chronic 
gastrointestinal inflammation and inflammation disrupts sleep, a vicious cycle may occur in which 
patients with IBD have sleep problems and those sleep problems create additional inflammation 
(Swanson et al., 2011).  
Recognizing the importance of studying sleep in IBD, studies using adult samples have 
begun to emerge. These studies indicated that adults with IBD report poor sleep quality (Keefer et 
al., 2006; Ranjbaran et al., 2007a; Zimmerman, 2003), have reduced sleep efficiency (Burgess et 
al., 2010), and have problems with obstructive sleep apnea (Keefer et al., 2006). Moreover, other 
studies have demonstrated a relation between increased disease activity and sleep disturbances in 
adults with IBD (Ali et al., 2013; Ananthakrishnan et al., 2013; Graff et al., 2011). Finally, adult-
based IBD research has linked sleep disruptions to increased fatigue (Graff et al., 2013) and 
decreased quality of life (Keefer et al., 2006; Ranjbaran et al., 2007a). These studies indicate that 
sleep problems and associated daytime sequelae are common among adults with IBD, which 
emphasizes the importance of continued research in this area.   
  Although several studies have examined disordered sleep in adults with IBD, relatively 
little research has been conducted in pediatric IBD samples. In the first study to investigate this 
topic, Nachimas and colleagues (2006) administered the Mini-Sleep Questionnaire to 41 Israeli 
children and adolescents with IBD (mean age = 16.9 years). Over half the sample (54%) reported 
having moderate or severe sleep disturbance, including daytime fatigue and night awakenings. 
However, the authors found no association between sleep problems and medical characteristics 
(e.g., disease activity, medications) in their sample. In addition, sleep disruptions and daytime 
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sleepiness were examined among a sample of 161 adolescents aged 10 to 18 years with IBD in 
comparison to age- and gender-matched healthy peers in Finland (Pirinen et al., 2010). The results 
revealed greater parent-reported problems with sleeping, nightmares, and daytime tiredness for 
adolescents with IBD compared to healthy adolescents. Interestingly, the adolescents did not 
endorse more sleep difficulties than their peers. In contrast, the authors reported an association 
between IBD symptom severity and sleep, such that adolescents with more severe IBD reported 
more sleep disturbance than those with mild IBD. However, the authors noted that they did not 
assess patient use of corticosteroids, which has been shown to disrupt sleep (Huscher et al., 2009), 
and thus they are unable to determine the mechanism underlying the sleep disturbance. 
Most recently, a study assessed the relations among sleep, psychological functioning, pain, 
and inflammation in youth (ages 9 to 17) with depression and CD (Benhayon et al., 2013). In 
contrast to Pirinen and colleagues’ (2010) findings, Benhayon and colleagues (2013) determined 
that adolescents with IBD reported more sleep difficulties than healthy adolescents. Greater 
subjective sleep disturbance among youth with IBD also was associated with increased self-report 
depression, anxiety, abdominal pain, as well as more severe physician-reported disease (i.e., 
Pediatric Crohn’s Disease Activity Index), but not inflammation, as assessed by blood assays. 
Moreover, qualitative sleep indicators (e.g., sleep quality, daytime sleepiness) were associated with 
anxiety, pain, and disease activity, while quantitative sleep indicators (e.g., sleep duration) were 
only associated with disease activity. However, because all variables, except disease activity, were 
assessed via self- or parent-report questionnaires, the association may have been due to the shared 
method variance rather than a true relation between the variables. 
The results of the aforementioned studies suggest that youth with IBD may be at risk for 
sleep disturbance and thus, it may be important to target sleep problems in future interventions 
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within this population. However, all previous studies of pediatric samples have utilized self- or 
parent-reported sleep assessments, which may be inaccurate estimates of sleep patterns due to 
social desirability or other biases. Moreover, if participants are poor historians, the use of 
retrospective questionnaires may not provide accurate data regarding sleep. Therefore, future 
research utilizing objective measures, such as polysomnography (PSG) and actigraphy, may 
provide more valid assessments of sleep patterns and disturbances. Although PSG is described as 
the “gold standard” for assessing sleep and diagnosing sleep disorders (Meltzer & Mindell, 2009), 
it involves participants staying overnight in sleep laboratory and is both expensive and time-
intensive. In contrast, actigraphy, wrist watch-like devices that assess movement, is a less 
expensive and intensive method of examining sleep patterns (Meltzer, Montgomery-Downs, Insana 
& Walsh, 2012). As a result, actigraphy allows researchers to more practically evaluate sleep 
patterns over time. Overall, research examining of sleep among youth with IBD is in its infancy 
and it is clear much additional research is needed to describe sleep/wake patterns in this population 
and investigate factors associated with these patterns. 
Pain 
One common symptom of IBD is abdominal pain. Individuals with IBD may experience 
abdominal pain during symptom flares as a result of intestinal inflammation or obstruction 
(Bielefeldt, Davis, & Binion, 2009). Although most patients’ pain is relieved during periods of 
disease quiescence, some individuals continue to experience some degree of pain despite having 
no indication of obstruction or inflammation (Bielefeldt, Davis, & Binion, 2009). Thus, 
abdominal pain may be considered a more chronic or continuous, rather than recurrent, symptom 
for some patients with IBD and should be monitored during periods of disease activity and 
remission. Moreover, it is important to investigate how and to what extent abdominal pain affects 
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functioning among individuals with IBD. Specifically, examining the association between pain 
and sleep patterns is critical as previous research has demonstrated that disrupted sleep can 
influence pain perception and ability to effectively cope with pain in children (Lewin & Dahl, 
1999).  
Currently, little research specifically has assessed the impact of abdominal pain on sleep 
patterns in patients with IBD. Most studies assessing the association between physical symptoms 
of IBD and sleep have focused on general measures of disease activity (Ali et al., 2013; 
Ananthakrishnan et al., 2013; Graff et al., 2011; Nachimas et al., 2006; Pirinen et al., 2010). To 
date, only one study explicitly has evaluated the relation between abdominal pain and sleep 
disturbance in pediatric IBD (Benhayon et al., 2013). As previously described, Benhayon and 
colleagues demonstrated a positive association between abdominal pain and sleep disturbance in 
youth with depression and CD. However, because this study utilized a sample with comorbid CD 
and depression, the results may not generalize to patients with UC or patients without depression. 
Thus, additional research regarding the relation of pain and sleep in pediatric IBD is warranted. 
Although few studies have examined the association between pain and sleep in IBD, 
literature using pediatric chronic pain conditions and in particular, functional abdominal pain, 
serves as a basis of why pain is an important factor to consider in sleep disturbance. Using a 
sample of 25 children and adolescents (ages 10-17) with functional abdominal pain (FAP) and a 
sample of 15 age- and gender-matched healthy children, Haim and colleagues (2004) determined 
that a greater percentage of children with FAP reported having poor sleep (42%) compared to 
healthy children (0%). More specifically, children with FAP reported frequently awakening from 
sleep due to abdominal pain, as well as experiencing pain when trying to fall asleep. Interestingly, 
no differences were demonstrated between groups with regards to sleep patterns as assessed by 
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actigraphy. This finding contradicts the results of other studies, which have demonstrated more 
night awakenings and decreased sleep efficiency as assessed by actigraphy among adolescents with 
chronic pain conditions (Palermo, Toliver-Sokol, Fonareva, & Koh, 2007). However, Haim and 
colleagues noted that their study was underpowered to examine differences in objective sleep 
measurements, which may have accounted for their lack of significant group differences.  
Additionally, a study by Huntley and colleagues (2007) investigated the association 
between sleep disturbance and pain while controlling for psychopathology (i.e., depression and 
anxiety disorder diagnoses) in 67 youth aged 8-15 years with FAP compared to 80 healthy peers. 
Results revealed greater parent- and child-reported sleep disturbance, including poorer sleep 
quality, more nightmares, and more problems falling asleep and staying asleep, in youth with FAP 
than in healthy children. No differences in total sleep time were demonstrated, suggesting youth 
with FAP may have more disruptions in sleep quality rather than duration. Moreover, the authors 
determined having pain was significantly associated with increased sleep disturbance above and 
beyond the influence of psychopathology.   
Taken together, the current literature indicates that pain is a critical factor to consider in the 
study of sleep in children and adolescents with IBD. Even though pain has only been examined in 
one study with pediatric CD, studies of other chronic pain samples suggest that pain is associated 
consistently with subjective sleep disruptions. However, the literature evaluating the relation of 
pain to objective sleep disturbance have yielded mixed results, indicating that additional research 
needs to be conducted to clarify this relation. Furthermore, previous studies in pediatric sickle cell 
disease have demonstrated a cyclical relation between pain and sleep problems, in which greater 
pain severity during the day is associated with worse sleep at night and worse sleep at night is 
associated with greater pain severity the next day (Valrie, Gil, Redding-Lallinger, & Daeschner, 
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2007). Therefore, future research should investigate the association between pain and sleep 
problems in pediatric IBD using a prospective design to determine if Valrie and colleagues’ (2007) 
results extend to other pediatric illness samples.  
Psychological Functioning 
 Given the unique issues of pediatric IBD, such as embarrassment and intrusiveness 
regarding intestinal symptoms (Banez, & Cunningham, 2009), much research has been conducted 
to examine the psychosocial functioning of these youth (Greenley et al., 2010; Mackner et al., 
2013). Overall, the research has demonstrated that children and adolescents with IBD have higher 
rates of internalizing symptoms (i.e., depression and anxiety) than samples of healthy children and 
youth with other pediatric chronic illnesses. In addition, disease severity, stress, family functioning, 
and maternal psychopathology have been correlated with internalizing symptoms in these youth 
with IBD (Greenley et al., 2010; Mackner et al., 2013). Because sleep disturbances have been 
associated with both depressive and anxious symptomatology among healthy children and 
adolescents (Chorney, Detweiler, Morris, & Kuhn, 2008), it makes sense that these associations 
may be present among youth with chronic medical conditions who have additional disease-related 
stressors. 
Among youth with IBD, only one study has explored the relation between psychological 
functioning and sleep (Benhayon et al., 2013). The results revealed an association between 
subjective sleep disturbance and internalizing symptoms such that youth who reported more 
sleep problems also reported greater depressive and anxious symptoms. However, as previously 
noted, this study has a number of limitations, including limited generalizability to youth with UC 
or without a diagnosis of depression, use of subjective measures only, and use of a               
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cross-sectional design that does not allow for conclusions regarding directionality or causality of 
associations. 
An examination of the pediatric chronic pain literature again provides additional rationale 
investigating the interplay between internalizing disorders and sleep. For example, Palermo and 
colleagues (2007) assessed sleep and associated factors, such as depression and worry before 
bedtime, among a sample of 20 adolescents (ages 12 to 17) with FAP, chronic headaches, 
myofascial pain, or type 1 complex regional pain syndrome. The authors found a relation 
between greater worry before bedtime and depressive symptoms and greater subjective sleep 
problems; however, objectively measured sleep was not significantly associated with depression 
or worry. This lack of association between internalizing symptoms and actigraphy results may be 
due to the way in which the authors analyzed the data. The authors chose to compute average 
measures of objective sleep to analyze this association rather than evaluating the relation of sleep 
and psychological symptoms in a prospective design, as Valrie and colleagues (2007) did in their 
sample of children with sickle cell disease. A prospective design may capture more variability in 
sleep patterns and psychological symptoms, and thus, may yield different results. Using a larger 
sample of adolescents with pain that was not related to a chronic disease, Palermo and colleagues 
(2011) determined pre-sleep arousal but not depressive symptoms were associated with greater 
subjective sleep disturbance. In a study of 26 female adolescents aged 12 to 17 years with 
musculoskeletal pain, Meltzer and colleagues (2005) also demonstrated a positive correlation 
between internalizing symptoms (i.e., depression and anxiety) and daytime sleepiness, but not 
between internalizing symptoms and nighttime sleep. The authors explained that their sample did 
not differ from a healthy sample of adolescents on total sleep time and this lack of difference, 
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coupled with the pain sample’s low ratings of depression and anxiety, may have accounted for 
the lack of significant relation between internalizing symptoms and nighttime sleep. 
Overall, youth with IBD may be at a greater risk for experiencing internalizing symptoms 
compared to their healthy peers and these symptoms may be related to more disrupted sleep. 
However, only one study has assessed the association between psychological symptomatology and 
sleep in pediatric IBD. Research from other pediatric chronic pain samples have produced mixed 
results regarding this relation, with some studies suggesting a significant relation exists (Palermo et 
al., 2007; Palermo et al., 2011) and other studies suggesting it does not (Meltzer et al., 2005). In 
addition, multiple methods of measuring sleep have been utilized (i.e., self-report measures, 
actigraphy), which may contribute to the discrepancies between studies. Given the limited 
literature, future research should continue exploring the association of internalizing symptoms and 
sleep in pediatric chronic medical conditions and specifically, in pediatric IBD, using a multi-
method approach.  
Health-related Quality of Life 
Health-related quality of life (HRQOL) has been defined as “a broad multidimensional 
concept that usually includes self-reported measures of physical and mental health” (CDC, 2012). 
HRQOL is commonly measured in pediatric psychology studies to assess youth adjustment to 
having a chronic medical condition (Palermo et al., 2008). In terms of pediatric IBD, many studies 
identified and described factors associated with HRQOL (Greenley et al., 2010; Mackner et al., 
2013). Findings from these studies reveal lower youth- and parent-reported HRQOL among 
children and adolescents with IBD compared to healthy peers. Moreover, corticosteroid use, 
greater disease severity, older age, ineffective coping skills, depression, and poor family 
functioning have been associated with worse HRQOL in these youth (Mackner et al., 2013).  
  12 
The association of sleep with HRQOL has been examined in several pediatric chronic 
medical conditions, including liver transplant recipients and juvenile idiopathic arthritis and 
juvenile dermatomyositis. For instance, Fredericks and colleagues (2012) assessed parent-reported 
sleep disturbance and HRQOL among 47 patients aged 2-17 years who had undergone liver 
transplants. Their results revealed that children who were reported to have sleep disturbance, 
especially periodic limb movements and daytime sleepiness, had lower parent-reported HRQOL. 
Additionally, lower child-reported school functioning was associated with more daytime 
behavioral sequelae (i.e., inattention and hyperactivity). Using a sample of 155 patients with either 
juvenile idiopathic arthritis or juvenile dermatomyositis (ages 8 to 16), another study demonstrated 
that sleep problems and fatigue were inversely related to HRQOL (Aviel et al., 2011). Specifically, 
greater parent- and child-reported sleep disruption and fatigue were associated with worse overall 
HRQOL and disease-specific quality of life. However, because both studies relied entirely on 
subjective measures, it is possible the associations were inflated due to shared-method variance and 
that utilization of objective measures may yield different results.  
Although no studies have examined the relation between sleep disturbance and HRQOL 
in pediatric IBD, Marcus and colleagues (2009) evaluated subjective fatigue and HRQOL in a 
sample of 70 children with IBD and 157 healthy children (ages 10-17). Compared to healthy 
youth, children and adolescents with IBD reported significantly poorer HRQOL and greater 
fatigue. Greater fatigue also was associated with worse HRQOL among youth with IBD. 
Moreover, youth with more severe IBD reported greater fatigue and poorer HRQOL than those 
youth with more mild disease. The results of this study provide some indication that an 
association between sleep problems and HRQOL may exist in pediatric IBD as fatigue and sleep 
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are closely linked. However, it is clear that future studies are needed to determine whether an 
actual relation between sleep disturbance and HRQOL exists in this population. 
Additionally, one study has investigated the associations among sleep problems, pain, 
depression, functional disability, and HRQOL in adolescents with various chronic pain conditions, 
including sickle cell disease, chronic headache, and juvenile idiopathic arthritis (Palermo & Kiska, 
2005). Their results demonstrated that greater reported sleep disturbance was related to greater 
depressive symptoms, more frequent reports of pain, increased functional disability, and reduced 
social and emotional HRQOL. Furthermore, depressive symptoms accounted for a significant 
amount of the variance in sleep disruption after controlling for the effects of pain, functional 
disability, and HRQOL. The authors explained that because their study utilized a cross-sectional 
design, future research should be conducted to explore the prospective associations between sleep, 
HRQOL, pain, and mood in pediatric samples.  
Previous research suggests that HRQOL is a critical factor to consider in the study of sleep 
of youth with IBD. Even though this association has not been examined in pediatric IBD, studies 
with other chronic illness groups suggest that HRQOL is associated consistently with sleep 
disruption. Lastly, Palermo and Kiska’s study (2005) suggests that the interplay between pain, 
mood, and HRQOL may be important to consider when studying sleep disturbance and promoting 
healthy sleep habits in youth with chronic medical conditions, including IBD. 
Summary of Relevant Literature and Rationale for Current Study 
IBD is characterized by an abnormal immune response and gastrointestinal inflammation, 
and consists of both Crohn’s disease and ulcerative colitis (CDC, 2014). Both disorders are marked 
by a number of symptoms, such as diarrhea, abdominal cramping and pain, rectal bleeding, weight 
loss, fever, delayed puberty, and osteoporosis (Kim & Ferry, 2004). The course of IBD is 
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unpredictable in nature, with periods of symptom flare-ups and disease quiescence (Banez & 
Cunningham, 2009). Treatment for IBD includes medication (e.g., aminosalicylates and 
corticosteroids), maintaining a healthy diet that excludes foods known to trigger symptoms, and 
potentially surgery if complications occur (CCFA, 2014). Given the increasing incidence of IBD in 
youth (Benchimol et al., 2011), much research has emerged regarding psychosocial functioning 
and disease sequelae, such as fatigue, among individuals with IBD. However, few studies have 
examined the role of sleep in pediatric IBD.    
Recent research has suggested there may be a bi-directional relation between sleep 
disruption and gastrointestinal inflammation in which patients with IBD have sleep problems and 
those sleep problems create additional inflammation (Swanson, Burgess, & Keskavazian, 2011). 
This has spawned a number of studies with adult patients with IBD, which have demonstrated that 
sleep problems and associated daytime sequelae are common in this population (Ali et al., 2013; 
Ananthakrishnan et al., 2013; Burgess et al., 2010; Keefer et al., 2006; Graff et al., 2011; Graff et 
al., 2013; Ranjbaran et al., 2007a; Zimmerman, 2003). Among pediatric IBD samples, far less 
research has been conducted on sleep disturbance (Benhayon et al., 2013; Nachimas et al., 2006; 
Pirinen et al., 2010). The results of these studies indicated youth with IBD may be at risk for sleep 
disturbance, including poor sleep quality, night awakenings, and daytime sleepiness. Furthermore, 
a positive association between disease activity and sleep disruption was demonstrated in two of the 
studies (Benhayon et al., 2013; Pirinen et al., 2010) However, all three pediatric studies are limited 
by their use of subjective sleep assessments that can be influenced by an individual’s biases. Thus, 
future research should consider using objective measures, such as PSG and actigraphy, to provide 
more accurate estimates of sleep patterns and disturbances in this population.  
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In addition to describing sleep patterns using multiple methods, it is important to determine 
what factors are associated with sleep disturbance based on previous research examining 
functioning of youth with IBD and research exploring psychosocial factors with other pediatric 
chronic medical conditions. Such research has revealed that children and adolescents with IBD 
experience high rates of internalizing symptoms (i.e., depression and anxiety) and poor HRQOL 
(Greenley et al., 2010; Mackner et al., 2013). Studies using pediatric chronic pain samples also 
have linked greater internalizing symptoms and worse HRQOL to greater sleep disruption (Aviel et 
al., 2011; Palermo et al., 2007). Moreover, abdominal pain is common symptom of IBD and 
research with pediatric FAP has demonstrated a positive association between pain and sleep 
disturbance (Haim et al., 2004; Huntley et al., 2007). Therefore, it seems reasonable that the 
aforementioned factors would be related to sleep problems among youth with IBD. 
However, only one study to date has evaluated the association between pain, psychological 
functioning, and sleep in pediatric IBD (Benhayon et al., 2013). The authors determined that youth 
who reported more sleep difficulties also reported greater depressive and anxious symptoms. 
Moreover, the results revealed an association between abdominal pain and sleep such that greater 
reports of pain were related to greater subjective sleep disturbance. Although this study added to 
the literature by examining factors related to sleep disruption in youth with IBD, it has a number of 
limitations, including limited generalizability to youth with UC or without a diagnosis of 
depression, use of subjective measures only, and use of a cross-sectional design that does not allow 
for conclusions regarding directionality or causality of associations. These limitations point to a 
need for future research using objective assessments, a prospective design, and a sample including 
both pediatric CD and UC.  
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Although no studies have explored the association between HRQOL and sleep in pediatric 
IBD, Marcus and colleagues (2009) found that poorer HRQOL was related to greater subjective 
fatigue among youth with IBD. These results suggest that more research needs to be conducted in 
this population, as fatigue and sleep are closely linked but are two separate constructs. Moreover, 
looking to the field of pediatric chronic pain provides rationale for investigating the interplay 
among sleep, pain, depression, and HRQOL. Using a sample of adolescents with various pain 
conditions, Palermo and Kiska (2005) demonstrated that greater depressive symptoms, more 
frequent reports of pain, and reduced social and emotional HRQOL were associated with more 
sleep disruption. Their results also indicated that depressive symptoms are strongly related to sleep 
disturbance after accounting for the effects of pain and HRQOL. However, given the cross-
sectional nature of Palermo and Kiska’s (2005) study, additional research should utilize 
prospective designs to explore the associations between sleep, HRQOL, pain, and mood over time. 
Taken together, the results of the aforementioned studies suggest that pain, disease activity, 
mood, and HRQOL may be important factors to consider in the investigation of sleep patterns and 
disturbances in children and adolescents with IBD. Moreover, these factors may be considered 
targets of future interventions designed to promote optimal sleep in this population. Therefore, the 
purpose of this study is to examine sleep patterns and associated factors, including pain, disease 
activity, mood, and health-related quality of life, in children and adolescents with IBD. More 
specifically, the specific aims and hypotheses of the current study are as follows:  
Aim 1: To describe objectively measured sleep patterns, including total sleep time, sleep onset 
latency, sleep efficiency and wake after sleep onset, and subjective sleep habits among children 
and adolescents with IBD and compare to data from previously published studies using healthy 
samples.  
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Aim 2: To examine the associations between subjective sleep patterns (1-week parent or 2-week 
patient retrospective report), objective sleep patterns (aggregated measures of total sleep time, 
sleep onset latency, sleep efficiency, and wake after sleep onset across 14-day study period), 
disease activity (at study enrollment), and health-related quality of life (2-week retrospective 
report) among children and adolescents with IBD. Based on previous research within samples of 
pediatric IBD and other chronic medical conditions (e.g., Benhayon et al., 2013; Pirinen et al., 
2010), the following hypotheses were proposed: 
• Hypothesis 2a: Youth who are rated by physicians as having greater disease activity will 
have greater subjective and objective sleep disturbance. 
• Hypothesis 2b: Youth who report worse health-related quality of life will have greater 
subjective and objective sleep disturbance. 
• Hypothesis 2c: Youth who have worse parent-reported health-related quality of life will 
have greater subjective and objective sleep disturbance. 
Aim 3: To examine the associations between objective sleep patterns, abdominal pain, and 
negative affect across a 14-day period among children and adolescents with IBD. Based on 
previous research within samples of pediatric IBD and other chronic medical conditions (e.g., 
Benhayon et al., 2013; Gil et al., 2003; Pirinen et al., 2010; Valrie et al., 2007), the following 
hypotheses were proposed: 
• Hypothesis 3a: Youth who report experiencing more intense pain during the day will have 
more objective sleep disturbance that night. 
• Hypothesis 3b: Youth who have more objective sleep disturbance at night will report 
experiencing more intense pain the next day. 
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• Hypothesis 3c: Youth who report more negative affect during the day will have more 
objective sleep disturbance that night. 
• Hypothesis 3d: Youth who have more objective sleep disturbance at night will report 
experiencing more negative affect the next day. 
Aim 4: To explore the association between objective sleep patterns and positive affect across a 14-
day period among children and adolescents with IBD. 
• Hypothesis 4: Because there is no previous literature on the association of positive affect 
and sleep, this aim was exploratory and thus, no hypothesis was generated. 
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Method 
Participants 
Fifty-one children and adolescents with IBD and their primary caregivers were approached 
regarding participation in the current study. Patients were recruited from West Virginia 
University’s pediatric gastroenterology clinic or via recruitment letters sent to all patients on the 
gastroenterology clinic registry. This study included children and adolescents who: a) were 
between ages 10 and 18 years; b) had a diagnosis of Crohn’s disease or ulcerative colitis for at least 
3-4 months (to help ensure patients have been medically stabilized after initial diagnosis); c) were 
either currently experiencing disease activity or in a period of disease quiescence; and d) had a 
primary caregiver who was willing to participate with the patient. Patients who were judged to be 
unable to complete the study questionnaires were not recruited for the current study. Of those 
approached, 40 patients agreed to participate (22% refusal rate). Reasons for refusal included lack 
of interest in the study (n = 4) and being too busy to complete study measures (n = 7). No 
significant differences in terms of patient age, gender, or race were demonstrated between 
participants and non-participants. Four additional participants withdrew from the study due to lack 
of interest. Ten participants did not complete the current study measures or actigraphy and were 
considered lost to follow-up. One participant was excluded from all analyses due to lack of self-
reported bedtimes and wake times and inability to corroborate actigraphy data. Demographic data 
for the final sample of 25 youth are presented in Table 3. The mean age of patients was 14.25 years 
(SD = 2.42) and 56% of the patients were male. Primary caregivers who participated were 
primarily mothers (88%). The majority (80%) of participants was diagnosed with Crohn’s disease 
and was in a state of disease remission (80%). Participants who were rated as being in a state of 
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disease remission did not significantly differ on demographic characteristics (i.e., age, gender, race, 
and ethnicity) compared to those who were rated as having active disease.  
Procedure  
During routine clinic appointments, potential participants were identified by healthcare 
staff and asked if they were interested in hearing about a research study. After participants agreed 
to hear about the study, a research assistant described the study’s purpose and procedures as well 
as potential risks and benefits of participation in a private clinic room. The research assistant also 
discussed confidentiality and HIPAA guidelines with the family. If participants agreed to the study, 
the research assistant obtained informed consent from the patient’s primary caregiver and patients 
aged 18; assent also was obtained from patients aged 8-18 In addition, a letter describing the 
study’s purpose and procedures was mailed to all eligible patients and their families in the patient 
registry in an effort to recruit patients who do not attend clinic appointments regularly. Families 
were instructed to contact research staff by phone if interested in participating. A member of the 
research staff then scheduled an appointment to review the consent and assent forms and 
questionnaires either over the phone, at clinic, the family’s home, or a mutually agreed upon public 
location. Phone numbers and/or email addresses of participating families were collected on the 
consent forms to contact them regarding reminders to complete study measures, to arrange to pick 
up study materials, if needed, and to contact families who won a gift card in the lottery at the end 
of the study. Of participants who completed the study, 23 were recruited in clinic, while three were 
recruited via mailings.  
After being consented, each family was given a packet of questionnaires that are unrelated 
to the current study to complete at home and send back using pre-addressed, stamped envelopes. 
After these questionnaires were received, a research assistant mailed out an actigraph, instructions 
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for actigraph use, a packet of questionnaires for participants to complete during the 14-day study 
period, and pre-addressed, stamped envelopes. This method was utilized to help determine the 
family’s trustworthiness in returning study questionnaires and equipment. Research assistants also 
called or emailed participants after packets were sent out to review instructions for completing the 
questionnaires and wearing the actigraph (also referred to as “actiwatch”). Patients were instructed 
to wear the actigraph on their non-dominant wrist at all times, except during bath time or when the 
actigraph may be submerged in water (e.g., washing dishes, swimming), for 14 days following 
receipt of study packet. Patients (or parents, depending on patient’s age) were instructed to depress 
a button on the actiwatch until it clicked at bedtime and upon awakening in the morning. The 
research assistant instructed families to consider the patient’s “first opportunity to attempt to sleep 
alone” as bedtime/time to depress the actiwatch button at night. The research assistant also 
instructed families to consider the time at which the patient “awoke in the morning without going 
back to sleep” as the patient’s wake time/time to depress the actiwatch button in the morning. In 
addition, families were instructed to complete the Sleep Diary with information regarding 
nighttime awakenings each morning. For the remainder of the daily measures (i.e., Sleep Diary nap 
information, Pain Diary, PANAS), patients were instructed to complete them as close to bedtime as 
possible in an effort to capture information from the entire day. 
Within each questionnaire packet, the parents completed the following questionnaires on 
day 1 (Time 1): a) Family Information Form (may be have been completed with patient if 
appropriate); and b) Child Sleep Habits Questionnaire. Also at Time 1, the patients completed the 
following questionnaires: a) Pain & Sleep Diary; b) Positive and Negative Affect Schedule for 
Children (PANAS-C); and c) Sleep Habits Survey. For days 2-13, patients completed the following 
measures in addition to wearing the actigraph: a) Pain & Sleep Diary; and b) Positive and Negative 
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Affect Schedule for Children. On day 14 (Time 2), both patients and parents completed the 
IMPACT-III. Table 1 displays the overall study flow. In addition to the questionnaire packets, the 
patient’s physician completed either the Pediatric Crohn's Disease Activity Index or the Pediatric 
Ulcerative Colitis Activity Index, depending on the patient’s diagnosis, when the patient was 
recruited in clinic. The physician was blinded to study data when completing the aforementioned 
measures of disease activity. The physician also reviewed the participants’ medical charts and 
recorded dates of symptom flares in the year prior to recruitment date.  
A research assistant called, emailed, and/or sent a text message (depending on family 
preference) to each family twice a week during the 14-day study period to remind them to 
complete the daily questionnaires and to answer any questions families had at the time. At the end 
of the study period, families mailed all questionnaires and actigraph equipment back to the WVU 
Department of Psychology using pre-addressed, stamped envelopes. If families did not mail the 
equipment back after completion of data collection, a research assistant called the family to arrange 
to pick up the study materials either at their home, in clinic, or a public location. For their 
participation in the study, families received up to $75 in gift cards and cash. For completion of 
Time 1 questionnaires, patients and parents each received a $10 gift card (total of $20 in gift 
cards). In terms of days 2-13, patients were paid $2.50 in cash for each day they completed the 
measures (i.e., Pain & Sleep Diary, PANAS-C, actigraphy). Moreover, patients received an 
additional $5 in cash if they completed all study measures during days 2-13. Similar to Time 1, 
patients and parents each received a $10 gift card for completion of Time 2 questionnaires. In 
addition, families who returned the actigraphy equipment in working order were entered into a 
lottery to receive one of five $50 gift cards (see Table 2 for schedule of participant remuneration). 
The lottery was conducted at the conclusion of all data collection. 
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Measures 
Family Information Form. The Family Information Form was created for this study to 
collect data on demographic and medical information about the patient and primary caregiver, such 
as patient and primary caregiver age, ethnicity, education level, and patient medical history. In 
addition, parents completed items on sleep health beliefs for their child and knowledge regarding 
sleep in youth that were based on questions from the Parental Knowledge of Healthy Sleep in 
Children (Owens, Jones, & Nash, 2011).  
Child Sleep Habits Questionnaire (CSHQ; Owens, Spirito, & McGuinn, 2000). The 
CSHQ is a 35-item parent-report questionnaire that assesses the sleep habits of children during the 
past week. Although the CSHQ was originally developed based on a sample of parents of children 
ages 4 to 10 years, it was completed by parents of all children in the current study. The CSHQ 
yields a total sleep disturbance score and eight subscales, including bedtime resistance, sleep onset 
delay, sleep duration, sleep anxiety, night wakings, parasomnias, sleep-disordered breathing, and 
daytime sleepiness. Parents rated their child’s sleep on a 3-point Likert-type scale (“usually/5 or 
more times a week,” “sometimes/2-4 times a week,” and “rarely/0-1 times a week”). Parents also 
indicated whether each sleep habit was a problem or not and whether their child was “very sleepy” 
or “falls asleep” during various daytime activities (e.g., eating meals, riding in a car). Finally, 
parents listed the child’s average bedtime and wake time, as well as average sleep duration on 
weekends and weekdays and average duration of night awakenings across the one-week period. 
Several items are reverse-scored, so higher scores indicated greater sleep disturbance. Subscales 
are calculated by summing relevant items, and the total sleep disturbance score is the sum of all 
subscales. Owens and colleagues (2000) reported high specificity and sensitivity for distinguishing 
between children with sleep disorders and those without sleep disorders. 
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For the current study, all subscales and the total sleep disturbance score were calculated to 
describe the patient’s sleep habits. In addition, average total sleep duration and night awakening 
duration during the past week was calculated to provide descriptive information for the sample. 
Within the current study, internal consistency for the total sleep disturbance was .68. Internal 
consistency for CSHQ subscales ranged from .08 (daytime sleepiness) to .82 (night wakings). 
Pain & Sleep Diary. The Pain & Sleep Diary was created for this study to collect data on 
each patient’s daily pain and sleep throughout the 14-day study period. Patients rated their 
abdominal pain intensity each day on a 0 to 10 Likert-type scale with 0 = “no pain” and 10 = 
“worst pain ever.” Patients also completed items regarding time and duration of night awakenings 
and daytime naps to corroborate data gathered from the actiwatches. In addition, planned wake 
time, reasons for nighttime awakenings, use of corticosteroids, as well as times of taking the 
actiwatch off and putting it back on were recorded in the diary.  
Positive and Negative Affect Schedule for Children (PANAS-C; Laurent et al., 1999). 
Patients completed the PANAS-C to assess positive and negative affect daily. The PANAS-C was 
specifically chosen because it assesses multiple dimensions of mood (including sadness and 
anxiety, which have been examined in previous literature [e.g., Benhayon et al., 2013], as well as 
positive aspects of mood, such as happiness) and is a self-report measure that can assess changes in 
mood on daily basis. The PANAS-C consists of 30 items, 15 assessing positive affect and 15 
assessing negative affect. Patients rated their mood using different words (e.g., happy, sad, 
nervous) on a 5-point Likert-type scale from 1 = “very slightly or not at all” to 5 = “extremely.” 
This questionnaire yields both positive and negative affect scores. To score each scale, the sum of 
the items for that scale was calculated. Higher scores equal greater negative or positive affect. 
Previous studies indicate the PANAS-C has good discriminant and convergent validity with       
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self-report, validated measures of anxiety and depression among children in grades 4 through 8 
(Laurent et al., 1999). In addition, this measure has been previously utilized in youth ages 11 to 20 
with sickle cell disease (Zempsky et al., 2013). For this study, both positive and negative affect 
scores were utilized. Cronbach’s alpha coefficients varied by day across the 14-day study period 
and ranged from .72 (on day 3) to .95 (on day 14) for negative affect and .81 (on day 11) to .96 (on 
day 3) for positive affect. 
Sleep Habits Survey (SHS; Wolfson & Caskadon, 1998). Youth completed the SHS to 
assess their perceptions of their sleep habits during the previous two weeks. The SHS is a 63-item 
measure of sleep habits and school performance; however, only the 40 items assessing sleep habits 
were utilized for this study. The SHS includes items that measure total sleep time, bedtime, and 
wake time on weekdays and weekends, as well as three subscales (sleepiness scale, sleep/wake 
problems scale, and morningness/eveningness scale). On the sleepiness scale, patients rated their 
level of sleepiness during various activities on a 4-point Likert-type scale (1 = “no sleepiness” to 4 
= “struggled to stay awake or fell asleep”). Higher scores indicate greater daytime sleepiness. 
Patients also rated the frequency of their problems with sleeping and waking from 1 = “never” to 5 
= “everyday,” with higher scores indicating greater sleep and wake problems. Lastly, patients 
completed the morningness/eveningness scale, which presents different scenarios to determine 
sleepiness and alertness in the morning versus evening. Higher scores indicate a morning 
preference while lower scores indicate an evening preference. Wolfson and colleagues (2003) 
found moderate to high correlations between the SHS and sleep diaries and actigraphy, indicating 
good convergent validity. For the current study, all three subscales were calculated to describe 
youth-reported sleep habits (i.e., sleepiness scale, sleep/wake problems scale, and 
morningness/eveningness scale). In addition, average total sleep time during the previous two 
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weeks was calculated for the sample. In the current study, the SHS demonstrated variable internal 
consistency for the subscales (i.e., sleepiness scale = .55, sleep/wake problems scale = .80, and 
morningness/eveningness scale  = .72).  
Pediatric Crohn's Disease Activity Index (PCDAI; Hyams et al., 1991). The PCDAI is a 
physician-report assessment of disease activity of children and adolescents with Crohn’s disease. 
The PCDAI is a 12-item questionnaire that assesses several domains related to disease activity in 
Crohn’s disease, including abdominal pain, stools, patient general well being, laboratory values, 
and physician examination questions. Scores on the abdominal pain, stools, and patient general 
well-being items range from 0 (“no/minimal problems”) to 10 (“severe problems”). Laboratory 
values are converted to a scoring system ranging either from 0 to 5 or 0 to 10. The physician 
examination items assess patient height, weight, tenderness of abdomen, perirectal disease, and 
extraintestinal manifestations, and can be categorized as 0, 5, or 10. Items are summed to create a 
total disease activity score. Total scores range from 0 to 100, with higher numbers corresponding 
to greater disease activity. Patients can be categorized as having “inactive disease” (scores less than 
10), “mild disease” (scores of 11-30), or “moderate to severe disease” (scores greater than 30). 
Studies of the PCDAI reveal good specificity and sensitivity for identifying periods of moderate or 
severe disease activity among youth aged 8 to 15 (Hyams et al., 2005). Patients were categorized 
into three aforementioned groups for subsequent analyses. 
Pediatric Ulcerative Colitis Activity Index (PUCAI; Turner et al., 2007). The PUCAI is a 
physician-report assessment of disease activity of children and adolescents with ulcerative colitis. 
The PUCAI is a 6-item questionnaire that assesses six disease activity domains: abdominal pain, 
rectal bleeding, stool consistency, number of stools per day, nocturnal stools, and activity level. 
Abdominal pain, stool consistency, and activity level items are rated on a 3-point scale (0, 5, 10), 
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while the items related to rectal bleeding and number of stools are rated on a 4-point scale (0, 10, 
20, 30 or 0, 5, 10, 15, respectively). Finally, the nocturnal stools item is rated as either 0 or 10. All 
items are summed to create a total disease activity score that ranges from 0 to 85, with higher 
scores indicating greater disease activity. Patients can be categorized into one of four groups: a) 
“disease remission” (scores less than 10), b) “mild disease” (scores of 10-34), c) “moderate 
disease” (scores of 35-64), and d) “severe disease” (scores greater than 65). For the current study, 
the categories of “moderate disease” and “severe disease” were combined into one group to enable 
consistency across the PCDAI and PUCAI: “moderate to severe disease” (scores greater than 35). 
The PUCAI has demonstrated good inter-observer reliability (ICC = .95) and convergent validity 
with other assessments of disease activity, such as colon appearance measured via colonoscopy, in 
samples of youth ages 3 to 18 years (Turner et al., 2007). Disease activity was analyzed using three 
categories of “remission,” “mild,” and “moderate to severe” disease.  
Actigraphy (Mini Mitter Actiwatch-64; Bend, Oregon). The Mini Mitter Actiwatch-64 is a 
wristwatch-like device used to assess sleep/wake patterns. The actiwatch measures sleep/wake 
patterns by using an accelerometer to monitor movement. The actiwatch was worn on the patient’s 
non-dominant wrist for 14 consecutive days. Patients (or parents, depending on the patient’s age) 
pressed a button on the actiwatch at bedtime and upon awakening in the morning, which places an 
event marker within the data being collected. The actiwatch was programmed to the 30-second 
epoch setting to allow for continuous monitoring during the 14-day study period. Based upon the 
movement data, several sleep-related measurements were determined using the Actiwatch 
software: a) sleep onset; b) sleep onset latency (i.e., time between reported bedtime and sleep 
onset); c) wake time; d) wake after sleep onset (i.e., minutes awake during sleep period); e) total 
sleep time (i.e., duration between sleep onset and wake time minus duration of wake after sleep 
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onset); and f) sleep efficiency (i.e., total sleep time divided by time in bed) (Meltzer et al., 2012). 
Sleep onset latency, total sleep time, sleep efficiency, and wake after sleep onset were used in 
analyses.  
A review of the literature on actigraphy use in pediatric samples determined that actigraphs 
have high sensitivity for identifying sleep and low specificity for identifying wake after sleep onset 
in comparison to polysomnography, videosomnography, and direct observation (Meltzer et al., 
2012). More specifically, studies using samples of ages similar to that of the current study and the 
Actiwatch-64 found sensitivities ranging from 78.1 – 96.5 and specificities ranging from 39.4 – 
52.6 (Hyde et al., 2007; O’Driscoll et al., 2009). However, actigraphy provides an objective 
method of assessing sleep/wake patterns that is more ecologically valid than the “gold standard” of 
sleep assessment, that being polysomnography. 
IMPACT-III (Otley et al., 2002; Otley et al., 2006). The IMPACT-III is a health-related 
quality of life measure designed for use in children and adolescents (ages 9 to 18 years) with IBD 
over the past two weeks. The IMPACT-III is a 35-item scale that assesses six areas of quality of 
life: bowel symptoms, systemic symptoms, emotional functioning, social functioning, body 
image, and treatment interventions. Patients rated their quality of life for each subscale using a 5-
point Likert-type scale. Scores are transformed from 0 – 5 to a 0 – 100 scale for interpretation (0 
= 100, 1 = 75, 2 = 50, 3 = 25, 4 = 0), with higher scores corresponding to greater quality of life. 
A total quality of life score and six individual domain scores can be obtained by computing the 
mean score of either all the questions answered (total score) or the mean score of the questions 
answered under the individual domain (individual domain scores). The IMPACT-III was 
responsive to change in quality of life based on disease activity (Otley et al., 2006). A previous 
version of the IMPACT-III demonstrated convergent validity with other measures of quality of 
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life (Otley et al., 2002). For the current study, this measure was adapted to create a parent-report 
version so parents also could provide proxy ratings of their child’s quality of life. Only the total 
quality of life score (parent and patient report) was used for study analyses. The IMPACT-III 
demonstrated high internal consistency for both the patient- and parent-report versions in this 
study (α = .91 and .93, respectively). 
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Results 
All statistical analyses were conducted through use of Predictive Analytics Software and 
Solutions version 21 (SPSS 21). 
Power analyses. 
  Statistical power for multilevel modeling approaches is based on the number of 
observations rather than the number of persons and allows for detection of effects using small 
sample sizes (Curran, Obeidat, & Losardo, 2010;Schwartz & Stone, 1998). Using a sample of 37 
adolescents with sickle cell disease, Gil and colleagues (2003) found medium to large effect sizes 
for the association of negative mood (β = 0.36, t = 8.55, p < .0001) and positive mood (β = – 0.4, t 
= –10.09, p < .0001) to same-day pain. In addition, Valrie and colleagues (2007) found a large 
effect size for the relation of sleep quality to pain severity in a sample of 20 children with sickle 
cell disease  (β = – 6.54, t = – 8.18, p < .01). Moreover, results of Benhayon and colleagues’ (2013) 
study of adolescents with CD revealed medium to large effect sizes regarding the association of 
sleep disturbance with disease activity (R2 = 21.6, p < .0001), anxiety (R2 = 8.6, p = .005), and 
abdominal pain (R2 = 15.7, p = .0001). Because the aforementioned studies used multilevel 
modeling techniques to examine variables similar to those in the current study, it is assumed that 
effect sizes in this study will be comparable. Therefore, this study aimed to recruit approximately 
25-30 participants to detect a medium to large effect size.  
Preliminary analyses. 
 All participants with at least seven days of diary and actigraphy data including both 
weekdays and weekends were retained in the final sample for analyses. First, all data were 
reviewed to locate any missing data for Aims 1 and 2, and to ensure that all missing data were 
random. Review of data revealed minimal amounts of missingness across study variables. Two 
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participants were missing data from the entire CSHQ and one participant was missing data from 
the entire SHS. These participants were excluded for relevant analyses in aim 2. Person-mean 
imputation (i.e., substituting the participant’s mean score of completed items on a scale for the 
items that were not completed) was utilized to address missingness for questionnaire data (i.e., 
SHS, CSHQ, IMPACT-III) for other participants (all who had less than 10% missing data). 
Imputation was not utilized to address missingness among diary data, PANAS-C, and actigraphy 
given that these data were examined utilizing multilevel modeling. Multilevel modeling allows for 
the analysis of unequal amounts of data and includes methods for handling missing data, such as 
multiple imputation and maximum likelihood estimations (Schwartz & Stone, 1998). 
 Next, study variables were examined for skewness, kurtosis, and outliers. These analyses 
revealed 5 outliers and 5 kurtoic variables (CSHQ bedtime resistance subscale, CSHQ sleep 
anxiety subscale, CSHQ parasomnias subscale, CSHQ sleep disordered breathing subscale, SHS 
sleep-wake problems subscale). No skewed variables were revealed. To attempt to correct these 
issues, square root, log, and inverse transformations were performed. These transformations 
corrected the outlier and kurtoic issues among three variables (CSHQ bedtime resistance subscale, 
CSHQ sleep anxiety subscale, SHS sleep-wake problems subscale) and these transformed variables 
were utilized in subsequent analyses. However, none of the transformations corrected the kurtosis 
or outlier issues for CSHQ parasomnias and CSHQ sleep disordered breathing subscales and 
therefore, the variables were retained in their original form. Descriptive statistics for all primary 
study variables are presented in Table 4. Additionally, frequency information for the parental 
beliefs and sleep knowledge questions from the FIF are presented in Table 5.  
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Aim 1. 
 The first aim was to describe objectively measured sleep patterns and subjective sleep 
habits. First, objective sleep data were aggregated across the 14-day study period for each 
participant using the four variables of interest (i.e., total sleep time, sleep onset latency, sleep 
efficiency, and wake after sleep onset). Next, means and standard deviations of each objective 
sleep variable and subjective sleep measures (CSHQ and SHS) were computed across participants 
(see Table 4 for complete descriptive information).  
 Objective and subjective sleep patterns also were compared to sleep patterns among 
samples of healthy youth from previously published studies (i.e., Meltzer, Walsh, Traylor, & 
Westin, 2012; Owens, Spirito, & McGuinn, 2000; Wolfson  & Carskadon, 2003) using t-tests. 
Compared to normatively developing youth (Owens, Spirito, & McGuinn, 2000), youth with IBD 
had significantly greater sleep duration (t = 3.49, p  = .002), night wakings (t = 2.71, p  = .013), and 
daytime sleepiness (t = 8.41, p  < .001) as reported on the CSHQ. Regarding actigraphy data, 
children and adolescents in the current study experienced significantly lower total sleep duration (t 
= - 2.13, p = .043), less wake after sleep onset (t = - 3.18, p  = .004), and greater sleep efficiency (t 
= 3.04, p  = .006) compared to healthy samples (Meltzer, Walsh, Traylor, & Westin, 2012). No 
significant differences were demonstrated on the SHS and other CSHQ subscales (see Table 6). 
Aim 2. 
 To examine the associations between sleep patterns, disease activity, and health-related 
quality of life, Pearson correlation coefficients were conducted with mean objective sleep 
variables, mean subjective sleep variables, mean parent- and child-reported HRQOL (IMPACT-
III), and patient age. Pearson correlation coefficients also were calculated using the mean square 
successive difference of each of the four objective sleep variables of interest (to assess            
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night-to-night instability in sleep patterns), mean parent- and child-reported HRQOL (IMPACT-
III), and patient age. The procedure for calculating mean square successive differences involved 
subtracting the value of each night (e.g., total sleep time) from the value of the next night and then 
squaring the difference for each individual in the study (Jahng, Wood, & Trull, 2008). In addition, 
Spearman correlations were conducted with disease activity categories (i.e., “remission,” “mild,” 
and “moderate to severe” disease), mean objective sleep variables, mean subjective sleep variables, 
and mean square successive differences of objective sleep variables. Moreover, Mann–Whitney U 
tests were calculated to determine if there were any significant differences in sleep variables 
between participants in a state of disease remission and participants experiencing active disease.  
 Results revealed that older youth experienced lower objective total sleep duration (r = - 
.502, p = .011). Given this significant finding, partial correlations controlling for patient age were 
conducted to examine associations among objective total sleep duration, mean parent- and child-
reported HRQOL (IMPACT-III), and disease activity categories; however, no significant 
associations emerged. Children and adolescents who reported having a higher morning preference 
on the SHS morningness/eveningness subscale reported greater HRQOL (r = .485, p = .016). 
Youth who experienced greater disease activity had more variable wake after sleep onset as 
recorded via actigraphy (ρ= .582, p = .002; U = 2.853, p  = .002). All other correlations and group 
comparisons were non-significant (see Tables 7 and 8 for full correlation tables).  
Aim 3. 
 Multilevel modeling with restricted maximum likelihood estimation was utilized to analyze 
the temporal patterns of objective sleep patterns, abdominal pain, and negative affect across the 14-
day study period. Separate models were conducted to examine the associations of sleep and pain, 
as well as sleep and negative affect. For each model, objective sleep patterns and abdominal pain 
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or negative affect were estimated as the within-person factors. Pain and negative affect scales were 
partialed into their overall average and person-centered components. This allows for the “average” 
portion to be interpreted similar to an ordinary least square regression as an estimate of between-
person effects. The person-centered component estimates the deviation from each person’s average 
and represents within-person change. Disease activity and patient age were estimated as the 
between-persons factors to determine if there are differences in the associations based upon 
whether a person is experiencing a symptom flare or is in a period of disease remission and any 
differences by age. To examine the hypotheses that youth who report more intense pain and 
negative affect during the day will have more objective sleep disturbance at night (hypotheses 3a 
and 3c), pain and negative affect variables were estimated to predict sleep that night. In addition, 
sleep variables were estimated to predict next-day pain and negative affect in order to determine if 
youth who have more objective sleep disturbance report more intense pain or negative affect the 
next day (hypotheses 3b and 3d).  
 Models of abdominal pain predicting sleep onset latency, sleep efficiency, wake after sleep 
onset, and total sleep time were designated as models A, B, C, and D, respectively, while the 
model of objective sleep variables (i.e., sleep onset latency, sleep efficiency, wake after sleep 
onset, and total sleep time) predicting abdominal pain was designated as model E. Additionally, 
models of negative affect predicting sleep onset latency, sleep efficiency, wake after sleep onset, 
and total sleep time were labeled models F, G, H, and I, respectively, while the model of objective 
sleep variables predicting negative affect was labeled model J. For the majority of multilevel 
models predicting sleep variables and negative affect or pain (i.e., models B, C, E, F, G, H, I, and 
J), a “Hessian” error occurred at the random effects level, indicating that the model was not a 
positive definite and did not converge due to lack of variability in the random effects (i.e., 
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individuals do not differ in association of pain or negative affect and sleep). However, removal of 
the person-centered components of pain, negative affect, and sleep variables addressed the non-
convergence issue and analyses were conducted without these variables at the random effects level. 
The random effects of models B, C, D, G, H, and I demonstrated that there is significant within 
person and between person variation in sleep variables to be accounted for in future models (see 
Tables 9 and 11 for full model information).  The random effects of models E and J also revealed 
that there is significant within-person and between-person variation in pain and negative affect, 
respectively, to be accounted for in future models (see Tables 10 and 12 for full model 
information). There were no significant random effects for any person-centered pain, negative 
affect, or sleep variables, indicating that these variables function the same way across individuals. 
In terms of fixed effects, patient age was a significant predictor of total sleep time in models D and 
I. Specifically, increased age was associated with decreased total sleep time (B = - 12.40, p = .008 
for model D; B = - 11.74, p = .013 for model I).  
 Finally, the association of night-to-night instability in objective sleep patterns, abdominal 
pain, and negative affect was examined using multilevel modeling. The square successive 
difference of each sleep variable was utilized as a within-persons factor along with abdominal pain 
and negative affect, and disease activity and patient age as the between-persons factors. For each 
multilevel model predicting night-to-night sleep instability and negative affect or pain, a “Hessian” 
error occurred suggesting that the model did not converge and there was not significant change in 
sleep instability, pain, or affect scores over time. Removal of person-centered variables and the 
intercept from the random effects level did not correct the non-convergence error. Thus, the 
multilevel model could not be applied and no further analyses were conducted. 
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Aim 4. 
 The fourth aim was to explore the associations between objective sleep patterns and 
positive affect across time. Again, multilevel modeling was utilized to analyze the temporal 
patterns of sleep and positive affect across the 14-day study period. Objective sleep patterns and 
positive affect were utilized as the within-person factors and disease activity and patient age were 
utilized as the between-persons factors for this aim. Similar to Aim 3, positive affect was partialed 
into its overall average and person-centered component. Positive affect was estimated to predict 
sleep that night and sleep variables were estimated to predict next-day positive affect. 
 Models of positive affect predicting sleep onset latency, sleep efficiency, wake after sleep 
onset, and total sleep time were designated models K, L, M, and N, respectively, while the model 
of objective sleep variables (i.e., sleep onset latency, sleep efficiency, wake after sleep onset, and 
total sleep time) predicting positive affect was designated model O. For the majority of multilevel 
models predicting sleep variables and positive affect (i.e., models L, M, N, and O), a non-
convergence “Hessian” error occurred at the random effects level. However, removal of the 
person-centered components of positive affect and sleep variables addressed the non-convergence 
issue and analyses were conducted without these variables at the random effects level. The random 
effects of models L, M, and N demonstrated that there is significant within person and between 
person variation in sleep variables to be accounted for in future models (see Table 13 for full 
model information). The random effects of model O also showed that there is significant within 
person and between person variation in positive affect to be accounted for in future models (see 
Table 14 for full model information). There were no significant random effects for any person-
centered positive affect or sleep variables, indicating that these variables function the same way 
  37 
across individuals. In terms of fixed effects, increased patient age was associated with decreased 
total sleep time in model N (B = - 12.07, p = .015). 
 In addition, the association between the square successive differences of each objective 
sleep variable and positive affect was examined using multilevel modeling. For each multilevel 
model predicting night-to-night sleep instability and positive affect, a “Hessian” error occurred 
suggesting that the model did not converge and there was not significant change in sleep instability 
or affect scores over time. Removal of person-centered variables and the intercept from the random 
effects level did not correct the non-convergence error. Thus, the multilevel model could not be 
applied and no further analyses were conducted.  
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Discussion 
 The current study had the following aims: 1) to describe objectively measured sleep 
patterns and subjective sleep habits among children and adolescents with IBD and compare to 
published studies using healthy samples; 2) to examine the associations between subjective sleep 
patterns, objective sleep patterns, disease activity, and HRQOL among children and adolescents 
with IBD; 3) to examine the associations between objective sleep patterns, abdominal pain, and 
negative affect across a 14-day period among children and adolescents with IBD; and 4) to explore 
the association between objective sleep patterns and positive affect across a 14-day period among 
children and adolescents with IBD. Contrary to hypotheses, no significant associations were 
demonstrated among objective sleep variables (i.e., total sleep time, sleep onset latency, wake after 
sleep onset, and sleep efficiency), abdominal pain, and negative affect. Additionally, positive affect 
was not significantly associated with objective sleep patterns. However, youth in the current study 
demonstrated significant differences in subjective and objective sleep compared to data on 
normatively developing peers from previously published articles. Associations between sleep 
variables and patient age, disease activity, and HRQOL also were exhibited.  
 Previous research has demonstrated a significant positive association between pain and 
sleep difficulties among youth with IBD (Benhayon et al., 2013) and FAP (Haim et al., 2004; 
Huntley et al., 2007; Palermo et al., 2007). However, the current study revealed no such 
association, which may be due to a number of differences between the current study and previous 
literature. First, prior research determined this association by comparing children and adolescents 
with IBD or FAP to healthy youth on sleep variables rather than examining the association of sleep 
and pain within the illness group. It may be that this association is more pronounced when 
comparing different groups rather than comparing within a group. Additionally, the majority of 
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previous research utilized samples of youth with FAP rather than pediatric IBD. Pain experienced 
by youth with FAP may be a different quality than that of children and adolescents with IBD given 
that IBD is characterized by gastrointestinal inflammation unlike FAP (Banez, & Cunningham, 
2009). Benhayon and colleagues’ study also is different from the current study in that they utilized 
a sample of youth with CD only and subjective sleep measures, while this study included both 
pediatric CD and UC and used objective sleep measurement (i.e., actigraphy) to examine the 
association of sleep and pain. Therefore, it is possible this previously demonstrated association 
might be accounted for by disease group differences or shared method variance.  
 Another potential explanation for these contradictory findings regarding pain and sleep, as 
well as for disease activity and sleep is the lack of variability in disease activity within this sample. 
In fact, the majority of patients (80%) were rated by their physicians as being in a state of disease 
remission or inactivity. The remaining 20% of participants were rated as experiencing mild disease 
activity, while 0% of participants experienced moderate or severe disease activity. This distribution 
is in stark contrast to Benhayon and colleagues’ study (2013), in which 68% of participants were 
experiencing disease activity. Because periods of disease remission/inactivity are marked by 
minimal physical symptoms such as pain (CCFA, 2014), it is possible that participants did not 
experience much abdominal pain throughout the study. Indeed, the average pain rating across the 
study was 0.93 out of 10 and participants reported pain levels of greater than 1 on only 24% of 
diary days. Thus, more variability in disease activity and pain may be necessary to produce 
significant associations among these variables and sleep. Future research should aim to include 
more heterogeneous samples of pediatric IBD to further elucidate the associations between IBD 
symptomatology and sleep disturbance. For example, future studies might employ more specific 
inclusion criteria regarding disease activity or pain severity (e.g., include only patients who are 
  40 
rated as experiencing a symptom flare). Studies may also consider using ecological momentary 
assessment (EMA) to evaluate pain and other variables (e.g., mood) in real time and increase data 
variability rather than rely on written diaries where participants potentially complete pain and 
mood ratings at the end of the data collection period thereby providing inaccurate ratings 
(Shiffman, Stone, & Hufford, 2008). 
 The lack of relation between affect and sleep also was unexpected given previous research 
suggesting an association between sleep and aspects of psychological functioning (e.g., Benhayon 
et al., 2013; Palermo et al., 2007). One reason for this finding may be the differences in 
measurement of psychological functioning. Prior studies specifically examined measures of 
depression and anxiety (e.g., Revised Child Anxiety and Depression Scale in Palermo and 
colleagues’ study); however, the current study utilized a more general measure of mood (i.e., 
PANAS-C). It may be that such internalizing symptoms (i.e., depression, anxiety) are more closely 
linked with sleep than broad-based negative affect. Although the PANAS-C contains items 
assessing aspects of depression (e.g., sad, lonely) and anxiety (e.g., feeling jittery, afraid), the 
association of these specific items with sleep may have been reduced by aggregating all negative 
affect items into a subscale. Examination of the association of the aforementioned individual items 
of the PANAS-C and sleep may have revealed more significant findings. Benhayon and colleagues’ 
(2013) study also only included youth with comorbid CD and depression, so their results may not 
generalize to the current sample, as participants were not screened for depressive symptomatology 
and likely did not exhibit significant levels of depressive symptoms. Moreover, the PANAS-C may 
not account for the unique psychological issues present within pediatric IBD, including 
intrusiveness and anxiety about gastrointestinal symptoms (Banez, & Cunningham, 2009). Instead, 
a recently developed measure of gastrointestinal-specific anxiety, the Visceral Sensitivity Index 
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(Labus et al., 2004), may better assess the psychological concerns of this population. 
Gastrointestinal-specific anxiety might demonstrate a significant association with disrupted sleep 
and thus, should be examined in future studies.    
While previous research has demonstrated a significant relation between sleep and HRQOL 
among various pediatric chronic illness populations (Aviel et al., 2011; Palermo & Kiska, 2005), 
this study’s findings did not support previous findings. The absence of a significant association 
may be due to differences between disease groups (e.g., symptom characteristics and frequency, 
type of treatment and course) because this is the first study to assess the relation between nighttime 
sleep and HRQOL within pediatric IBD. However, the current study findings also are inconsistent 
with Marcus and colleagues’ (2009) results regarding daytime fatigue and HRQOL. These 
conflicting results may be a function of different time frames and administration time points of 
study measures. For example, the IMPACT-III and SHS refer to a two-week time period, while the 
CSHQ assesses sleep over a one-week time period. The SHS and CSHQ also were administered on 
day 1, while the IMPACT-III was administered on day 14 (see Table 1 for study timeline). For 
example, it is possible that HRQOL on day 14 is correlated with sleep disruption at day 14, but this 
association was not captured by the current study given the different administration points. 
Moreover, aggregating the objective sleep variables across the 14-day study period to enable 
comparison with the IMPACT-III eliminated the within-person sleep variability and potentially 
reduced the association between these variables.  
 Although some of the study hypotheses were not supported, a few interesting significant 
findings emerged. Consistent with Pirinen and colleagues’ study (2010), parents reported that their 
children experienced greater sleep disruptions (specifically night wakings and daytime sleepiness) 
as compared to healthy youth from previously published studies. In addition, no differences in 
  42 
youth-reported sleep disturbance were reported in either study. However, the current study’s results 
regarding actigraphic sleep contradict findings of a previous study of adolescents with various 
chronic pain conditions (Palermo et al., 2007). More specifically, Palmero and colleagues 
determined that adolescents with chronic pain experienced lower sleep efficiency and more night 
wakings than normatively developing peers, while the current study found greater sleep efficiency 
and less wake after sleep onset when compared to data from published articles using samples of 
healthy youth. Inconsistencies in study results may be due to sample differences as the current 
study involved a sample of pediatric IBD while Palmero and colleagues utilized a sample of 
various chronic pain conditions. Palermo and colleagues’ sample also reported significantly higher 
levels of pain (mean usual pain = 6.6 out of 10) than the current sample, which may account for the 
differences in findings. Additionally, given the high number of statistical analyses that were 
conducted, one cannot discount the possibility that this study’s findings are the result of type I error 
and may be spurious.  
 Furthermore, this study revealed that older youth experienced lower actigraphic total sleep 
duration, which conflicts with prior pediatric IBD research (Nachmias et al., 2006) but aligns with 
research of normatively developing samples (e.g., Wolfson & Carkadon, 1998). It may be that 
differences in measurement of sleep accounted for the discordant findings. Specifically, Nachmias 
and colleagues utilized a self-report sleep questionnaire, which may have resulted in inaccurate 
estimates of sleep due to social desirability bias or participants being poor historians of their own 
sleep. Regarding the association of disease activity and sleep among youth with IBD, mixed results 
have been demonstrated with some studies revealing that greater disease activity correlated with 
greater sleep disturbance (Benhayon et al., 2013) and others finding no such association (Nachmias 
et al., 2006). The current study adds to the literature base by providing additional evidence for the 
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potential negative association between sleep and disease activity as increased instability in wake 
after sleep onset was demonstrated among youth experiencing more active disease. Lastly, 
morningness preference (i.e., preference for completing cognitive and physical activities during the 
morning time as opposed to afternoon or evening) was positively associated with better HRQOL. 
Randler (2011), who demonstrated similar results among a sample of normatively developing 
adolescents, postulated that morningness may serve as a protective factor against a host of 
emotional and physical health problems. It may be important for clinicians to screen for 
morningness/eveningness preference during routine clinic visits in effort to identify youth with 
IBD who are at risk for greater psychosocial issues. However, as mentioned previously, these 
results may be influenced by type 1 error and should be interpreted with caution.  
 The current results should be considered in the light of study limitations. First, the current 
sample included children and adolescents spanning a wide age range (i.e., 10-18 years). Although 
use of this age range allows for increased generalizability of results, there are drastic changes 
regarding sleep patterns that occur between childhood and adolescence. Specifically, decreasing 
sleep duration, slow wave sleep, and latency to REM sleep have been correlated with increasing 
age among youth (Ohayon, Carskadon, Guilleminault, & Vitiello, 2004). Such differences in sleep 
patterns were reflected in this study’s results in that older youth experienced less objective total 
sleep time. However, some age-related correlations may have been reduced within the current 
study due to the small sample size. Future studies that include a larger sample size of youth with 
IBD should be conducted to replicate these results and determine if any additional age-related 
associations exist within this population. Although the study’s sample size should provide enough 
statistical power to detect medium to large effects based on previous literature that used similar 
statistical techniques and examined similar constructs, it is possible the results were impacted by 
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type II error and the study was underpowered to detect significant associations. Thus, additional 
research using larger sample sizes of youth with IBD may yield hypothesized associations among 
sleep, pain, and mood.  
 The current study also had a number of measurement issues that may have impeded results. 
For example, both the SHS and CSHQ demonstrated substandard internal consistency on several 
subscales. As a result, it is possible that these questionnaires did not measure the same underlying 
construct (i.e., sleep patterns) and impacted the study findings. The low internal consistency of the 
CSHQ and SHS subscales may be due to these measures being developed and validated for 
different age ranges (i.e., 4-10 years for CSHQ and 13-19 years for SHS) than the current sample 
(i.e., 10-18 years). However, the aforementioned measures were chosen because they are both 
assess multiple dimensions sleep dysfunction (e.g., daytime sleepiness, sleep/wake schedules), 
utilize Likert-type scales that allow for increased response variability (rather than yes/no format of 
other measures such as the Pediatric Sleep Questionnaire; Chervin et al., 2000), and assess a 
relatively short time period (i.e., 1-2 weeks retrospective report rather than 3-6 months 
retrospective report). Although the child version of IMPACT-III has been well validated for use in 
pediatric IBD (Otley et al, 2002; Otley et al., 2006), the parent version of this questionnaire has not 
been validated. Future studies may want to employ more rigorous psychometric testing of the 
parent proxy IMPACT-III as it has demonstrated promising results in terms of reliability (i.e., 
excellent internal consistency within the current study) and concordance with the child version 
(Gallo et al., 2014). Moreover, a parent proxy measure of HRQOL may be a desirable clinical tool 
if youth have cognitive or other limitations (e.g., too fatigued or ill) that preclude use of a self-
report form (Eiser & Morse, 2001). Finally, actigraphy is not considered the “gold standard” for 
sleep assessment. More specifically, actigraphs have demonstrated high sensitivity for identifying 
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sleep, but low specificity for identifying wake after sleep onset (Meltzer et al., 2012). It is possible 
that actigraphy may not have accurately identified certain aspects of sleep disturbance in the 
current study (e.g., wake after sleep onset, sleep efficiency) and impacted study results.   
 In conclusion, some of the study hypotheses were not supported by the findings. No 
significant associations were exhibited for sleep patterns with pain, negative affect, or positive 
affect. However, positive associations between disease activity and sleep disturbance, as well as 
health-related quality of life and morningness were demonstrated. Moreover, it is encouraging that 
children and adolescents who are in disease remission are experiencing good quality sleep and few 
emotional problems. This reinforces the importance of psychologists supporting their physician 
colleagues in helping youth to manage their IBD and achieve remission status by screening and 
providing recommendations to promote adherence to treatment regimens and medical 
appointments (Hommel et al., 2013). It also is worth nothing that the current study had several 
methodological strengths. This study utilized a multi-method, multi-informant approach including 
use of objective sleep data, which is less susceptible to biases associated with subjective 
measurement. Use of such an approach lessens the probability of finding significant associations 
due to shared method variance. In addition, a prospective study design allows for investigation of 
temporal associations between study variables and directionality of these associations. To analyze 
these associations, multilevel modeling was utilized. This statistical approach allows for the 
examination of data at the within-person level (i.e., changes in an individual across time) and the 
between-persons level (i.e., differences between participants), as well as procedures for analyzing 
unequal amounts of data and missing data (Curran, Obeidat, & Losardo, 2010). Moreover, because 
multilevel modeling draws its statistical power from the number of observations rather than the 
number of persons (Curran, Obeidat, & Losardo, 2010; Schwartz & Stone, 1998), use of relatively 
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small sample sizes with a large number of observations, like the current study, can have sufficient 
statistical power to detect effects. However, it is critical to have diversity in terms of disease 
activity and pain severity when utilizing small sample size to ensure there is sufficient variability 
among these variables. Future research using longer assessment periods (e.g., three months) and 
more valid assessment approaches (e.g., EMA) may capture the waxing and waning course of IBD 
symptoms symptomatology (CCFA, 2014) and provide further insight on intra-individual 
variability in the association of pain or disease activity and sleep.   
 Because sleep disruption and circadian rhythm may be associated with gastrointestinal 
inflammation (Swanson, Burgess, & Keskavazian, 2011) and inflammatory processes have been 
linked to sleep disturbance (Ranjbaran et al., 2007b), it is essential to investigate sleep within 
pediatric IBD. This may be especially important among youth with moderate to severe disease 
activity, who were not adequately represented in the current sample. It also is necessary to identify 
variables that are amendable to intervention (e.g., mood, pain) in efforts to promote sleep in this 
population. Future research should continue to assess sleep patterns using multiple subjective and 
objective methods, including polysomnography, and potentially associated factors (e.g., GI-
specific anxiety, functional disability). Such research may provide insight on how to foster 
psychosocial functioning and optimal health outcomes among children and adolescents with IBD. 
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Table 1 
Study Timeline 
Time Patient measures Parent measures Physician measures 
Time 1 
(Day 1) 
1) Pain & Sleep Diary 
2) Positive and Negative 
Affect Schedule for 
Children 
3) Sleep Habits Survey  
 
1) Family Information 
Form 




Disease Activity Index 
or Pediatric Ulcerative 
Colitis Activity Index 
(depending on patient 
diagnosis) 
 
Days 2 – 
13a  
1) Pain & Sleep Diary 
2) Positive and Negative 







1) Pain & Sleep Diary 
2) Positive and Negative 







a Measures completed daily during this time period 
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Table 2 
Schedule of Participant Remuneration 
Time Patient remuneration Parent remuneration 
 
Time 1 (Day 1) measures 
 
 
$10 gift card 
 
$10 gift card 
Days 2 – 13 measures 
 
$2.50 per completed diary 
day ($30 for 12 days) 




Time 2 (Day 14) measures 
 
$10 gift card $10 gift card 
Equipment returned 
 









Variables (N = 25) n (%) Mean SD Range 
Patient age (in years) 
 
 14.25 2.42 10 – 18  
Patient gender 
    Male 









    White 





   
Diagnosis 
    Crohn’s disease 





   
PCDAI total score 
   Inactive disease 
   Mild disease 






7.5 7.12  0 – 30  
PUCAI total score 
   Disease remission 
   Mild disease 






7 9.75 0 – 20  
Number of symptom flares in past year 
   0 flares 
   1 flare 
   2 flares 







   
Primary caregiver relationship 
    Mother 
    Father 
    Grandmother2 








   
Primary caregiver age (in years) 
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Family structurea 
   Intact 
   Blended 
   Single 






Mother highest education level 
   Graduated from high school 
   Some college or specialized training 
   Bachelor’s degree 







   
Father highest education level 
   7th, 8th, or 9th grade 
   Graduated from high school 
   Some college or specialized training 
   Bachelor’s degree 
   Master’s or doctoral degree 










   
Total family income 
   Less than $10,000 
   $10,000 – 14, 999 
   $15,000 – 24,999 
   $25,000 – 34,999 
   $35,000 – 49,999 
   $50,000 – 74,999 
   $75,000 – 99,999 
   $100,000 – 149,999 











   
a Intact = married to other biological parent; blended = remarried to step-parent; single = never 
been married, divorced, widowed, or living with boyfriend/girlfriend 
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Table 4 
Descriptives of study variables 
 
Variables   
(N = 25, except where noted) 
Mean SD  Possible Range 
(except where noted) 
SHS sleepiness scalea 
 
13.13 2.79 15 – 75  
SHS sleep/wake problems behavior scalea 
 




28.08 4.46 10 – 43  
SHS weekday sleep duration (in minutes)a 
 
447.04 70.90 312 – 580e 
SHS weekend sleep duration (in minutes)a  
 
572.78 75.58 480 – 737 e 
CSHQ total sleep disturbance scoreb 
 
44 4.93 33 – 99 
CSHQ bedtime resistanceb 
 
7.39 2.55 6 – 18  
CSHQ sleep onset delayb 
 
1.52 0.73 1 – 3  
CSHQ sleep durationb 
 
4.83 1.95 3 – 9  
CSHQ sleep anxietyb 
 
4.91 2.23 4 – 12 
CSHQ night wakingsb 
 
4.13 1.10 3 – 9  
CSHQ parasomniasb 
 
7.70 1.52 7 – 21  
CSHQ sleep disordered breathingb 
 
3.09 0.60 3 – 9  
CSHQ daytime sleepinessb 
 
13.04 1.94 8 – 24  
CSHQ sleep duration (in minutes)c 
 
486.82 50.96 420 – 600 e  
CSHQ night waking duration (in minutes)d 
 
11.37 15.74 0 – 60 e 
Actigraphy total sleep time (in minutes) 
 
409.81 56.91 326.18 – 514 e  
Actigraphy sleep onset latency (in minutes) 
 
5.65 3.72 0 – 14.73 e 
Actigraphy wake after sleep onset (in 
minutes) 
54.36 23.35 9 – 121.15 e 
  62 
Actigraphy sleep efficiency 
 
85.01% 4.46% 73.93 – 93.34% e 
PANAS-C negative affect  
 
19.04 4.21 15 – 75  
PANAS-C positive affect 
 
43.81 12.86 15 – 75 
Average self-report abdominal pain 
 
0.93 1.24  0 – 10 
IMPACT – III youth total score 
 
76.37 11.93 0 – 100 
IMPACT – III parent total score 74.71 13.26 0 – 100 
a n = 24 
b n = 23 
c n = 22 
d n = 19 
e current sample range  
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Table 5 
Descriptives of Parental Beliefs and Knowledge Questions 
 
Questions (N = 25) n (%) 
I believe my child gets enough sleep. 
   Agree 
   Disagree 





I believe my child has healthy sleep habits. 
   Agree 
   Disagree 





Children who don’t get enough sleep are more likely to be 
underweight than overweight. 
   True 
   False 






Snoring in a child indicates that he or she is sleeping well. 
   True 
   False 





Being either under or over-active can both be warning signs that 
a child is not getting enough sleep. 
   True 
   False 






Watching TV in their bedroom makes it more difficult for 
children to fall asleep. 
   True 
   False 






Children should have the same bedtime and wake time on 
weekdays and weekends. 
   True 
   False 






Children only need a bedtime routine if they are having trouble 
falling asleep. 
   True 
   False 
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Well-rested children don’t need an alarm clock to wake up in the 
morning. 
   True 
   False 






The average preschooler (3-5 years) needs about 10 hours of 
sleep/24hrs. 
   True 
   False 






Being overweight can increase a child’s risk of sleep problems. 
   True 
   False 





The average school-aged child (6-12 years) needs about 8 hours 
of sleep. 
   True 
   False 
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Table 6 







t p df 
CSHQ bedtime 
resistancea 
7.39 (2.55) 7.06 (1.89) .62 ns 22 
CSHQ sleep onset delaya 1.52 (0.73) 1.25 (0.53) 1.78 ns 22 
CSHQ sleep durationa 4.83 (1.95) 3.41 (0.93) 3.49 .002 22 
CSHQ sleep anxietya 4.91 (2.23) 4.89 (1.45) .05 ns 22 
CSHQ night wakingsa 4.13 (1.10) 3.51 (0.89) 2.71 .013 22 
CSHQ parasomniasa 7.70 (1.52) 8.11 (1.25) - 1.31 ns 22 
CSHQ sleep disordered 
breathinga 
3.09 (0.60) 3.24 (0.63) - 1.23 ns 22 
CSHQ daytime 
sleepinessa 
13.04 (1.94) 9.64 (2.80) 8.41 .001 22 
SHS sleepinessb  13.13 (2.79) 14.03 (3.51) - 1.59 ns 23 
SHS sleep-wake 
problemsb 
17.96 (6.90) 18.48 (6.63) - .37 ns 23 
Actigraphy total sleep 
time (in minutes)c 
409.81 
(56.91) 
434.10 (60.90) - 2.13 .043 24 
Actigraphy wake after 
sleep onset (in minutes) c 
54.36  
(23.35) 







3.04 .006 24 
Note: ns = non-significant 
a Healthy comparison data taken from Owens, Spirito, & McGuinn, 2000 
b Healthy comparison data taken from Wolfson  & Carskadon, 2003 
c Healthy comparison data taken from Meltzer, Walsh, Traylor, & Westin, 2012
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Table 7 








CSHQ total sleep 
disturbance 
- .06 - .11 .21 - .15 
CSHQ bedtime resistance - .10 .05 - .19 .06 
CSHQ sleep onset delay - .21 - .15  .22 .02 
CSHQ sleep duration - .15 - .28 .22 - .02 
CSHQ sleep anxiety - .17 - .20 - .02 .21 
CSHQ night wakings -. 24 - .35 .15 < .01 
CSHQ parasomnias .06 .12 .23 - .21 
CSHQ sleep disordered 
breathing 
- .12 - .16 .12 .15 
CSHQ daytime sleepiness - .04 .10 - .26 - .08 
SHS sleepiness  - .38 - .34 .17 .31 
SHS sleep-wake problems - .14 - . 02 - .03 .12 
SHS morningness-
eveningness 
.49* .31 - .13 - .20 
Note: * p < .05, ** p < .01 
 
a Pearson correlation coefficients 
 
b Spearman rank correlation coefficients
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Table 8 








Actigraphy total sleep 
time 
- .30c - .10c .19c - .50* 
Actigraphy sleep onset 
latency 
.01 < - .01 .33 - .04 
Actigraphy wake after 
sleep onset 
.05 . 02 .10 - .09 
Actigraphy sleep 
efficiency 
- .03 - .06 - .07 - .19 
Actigraphy total sleep 
time instability 
- .08 .01 .17 .08 
Actigraphy sleep onset 
latency instability 
.15 .16 .15 - .16 
Actigraphy wake after 
sleep onset instability 
- .01 - .01 .58** < - .01 
Actigraphy sleep 
efficiency instability 
- .02 .13 .17 .07 
Note: * p < .05, ** p < .01 
 
a Pearson correlation coefficients except where noted 
 
b Spearman rank correlation coefficients except where noted 
 
c Partial correlation coefficients controlling for patient age
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Table 9 
Multilevel Models of Abdominal Pain Predicting Sleep Variables 
Model A: Sleep onset latency 
Fixed effects Β SE p 
Disease activity – inactive   - 2.81 5.04 ns 
Patient age - .10 .33 ns 
Mean pain - .30 .67 ns 
Person-centered pain 2.78 1.32 ns 
Random effects 
Intercept 3.09 4.72 ns 
Person-centered pain 12.79 13.97 ns 
Model B: Sleep efficiency 
 Β SE p 
Fixed effects 
Disease activity – inactive  - .24 2.38 ns 
Patient age - .37 .40 ns 
Mean pain .37 .78 ns 
Person-centered pain - .21 .39 ns 
Random effects 
Intercept 18.71 6.75 .006 
Model C: Wake after sleep onset 
Fixed effects Β SE p 
Disease activity – inactive  - 2.36 12.63 ns 
Patient age - .80 2.12 ns 
Mean pain - 1.39 4.17 ns 
Person-centered pain - .29 1.44 ns 
Random effects 
Intercept 579.25 190.92 .002 
Model D: Total sleep time 
Fixed effects Β SE p 
Disease activity – inactive  - 19.16 25.61 ns 
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Patient age - 12.40 4.25 .008 
Mean pain 7.85 8.41 ns 
Person-centered pain 4.97 6.04 ns 
Random effects 
Intercept 1799.75 785.13 .022 
Person-centered pain 6.17 208.59 ns 
Note: ns = non-significant  
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Table 10 
Multilevel Model of Sleep Variables Predicting Abdominal Pain  
Model E: Next day pain 
Fixed effects Β SE p 
Disease activity – inactive  - .35 .74 ns 
Patient age .10 .14 ns 
Mean sleep onset latency - .04 .13 ns 
Mean sleep efficiency - .07 .25 ns 
Mean wake after sleep onset - .01 .04 ns 
Mean total sleep time  .01 .01 ns 
Person-centered sleep onset 
latency 
< - .01 .01 ns 
Person-centered sleep 
efficiency 
< - .01 .02 ns 
Person-centered wake after 
sleep onset 
< .01 < .01 ns 
Person-centered total sleep 
time  
< - .01  < .01 ns 
Random effects 
Intercept 1.70 .59 .004 
Person-centered sleep 
efficiency 
< .01 .01 ns 
Person-centered total sleep 
time 
< .01 < .01 ns 
Note: ns = non-significant 
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Table 11 
Multilevel Models of Negative Affect Predicting Sleep Variables 
Model F: Sleep onset latency 
Fixed effects Β SE p 
Disease activity – inactive  - 2.45 1.95 ns 
Patient age - .18 .32 ns 
Mean negative affect - .21 .19 ns 
Person-centered negative 
affect 
.15 .17 ns 
Random effects 
Intercept 1.36 4.43 ns 
Model G: Sleep efficiency 
 Β SE p 
Fixed effects 
Disease activity – inactive  - .60 2.31 ns 
Patient age - .39 .39 ns 
Mean negative affect - .19 .23 ns 
Person-centered negative 
affect 
 .01 .08 ns 
Random effects 
Intercept 17.95 6.49 .006 
Model H: Wake after sleep onset 
Fixed effects Β SE p 
Disease activity – inactive  - .45 12.08 ns 
Patient age - .55 2.05 ns 
Mean negative affect 1.49 1.18 ns 
Person-centered negative 
affect 
- .09 .30 ns 
Random effects 
Intercept 535.86 177.16 .002 
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Model I: Total sleep time 
Fixed effects Β SE p 
Disease activity – inactive  - 21.93 25.74 ns 
Patient age - 11.74 4.32 .013 
Mean negative affect .68 2.52 ns 
Person-centered negative 
affect 
.14 1.24 ns 
Random effects 
Intercept 1874.16 808.05 .020 
Note: ns = non-significant 
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Table 12 
Multilevel Model of Sleep Variables Predicting Negative Affect 
Model J: Next day negative affect 
Fixed effects Β SE p 
Disease activity – inactive  - 1.51 2.43 ns 
Patient age - .37 .47 ns 
Mean sleep onset latency - .56 .41 ns 
Mean sleep efficiency - .80 .81 ns 
Mean wake after sleep onset - .08 .13 ns 
Mean total sleep time  .03 .03 ns 
Person-centered sleep onset 
latency 
.03 .03 ns 
Person-centered sleep 
efficiency 
.06 .08 ns 
Person-centered wake after 
sleep onset 
 < .01 .02 ns 
Person-centered total sleep 
time  
< - .01 < .01 ns 
Random effects 
Intercept 17.84 6.49 .006 
Note: ns = non-significant
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Table 13 
Multilevel Models of Positive Affect Predicting Sleep Variables 
Model K: Sleep onset latency 
Fixed effects Β SE p 
Disease activity – inactive  - 2.34 1.89 ns 
Patient age - .02 .32 ns 
Mean positive affect - .08 .06 ns 
Person-centered positive 
affect 
.03 .14 ns 
Random effects 
Intercept .72 4.13 ns 
Person-centered positive 
affect 
.12 .17 ns 
Model L: Sleep efficiency 
 Β SE p 
Fixed effects 
Disease activity – inactive  - .44 2.34 ns 
Patient age - .34 .42 ns 
Mean positive affect < - .01 .08 ns 
Person-centered positive 
affect 
- .04 .05 ns 
Random effects 
Intercept 18.42 6.66 .006 
Model M: Wake after sleep onset 
Fixed effects Β SE p 
Disease activity – inactive  - 1.15 12.40 ns 
Patient age - 1.31 2.21 ns 
Mean positive affect - .19 .42 ns 
Person-centered positive 
affect 
.23 .20 ns 
Random effects 
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Intercept 565.79 186.66 .002 
Model N: Total sleep time 
Fixed effects Β SE p 
Disease activity – inactive  - 22.27 25.82 ns 
Patient age - 12.07 4.56 .015 
Mean positive affect - .06 .86 ns 
Person-centered positive 
affect 
.54 .83 ns 
Random effects 
Intercept 1887.87 811.56 .020 
Note: ns = non-significant 
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Table 14 
Multilevel Model of Sleep Variables Predicting Positive Affect 
Model O: Next day positive affect 
Fixed effects Β SE p 
Disease activity – inactive  3.77 7.60 ns 
Patient age - 1.81 1.48 ns 
Mean sleep onset latency .87 1.30 ns 
Mean sleep efficiency - .18 2.54 ns 
Mean wake after sleep onset - .09 .41 ns 
Mean total sleep time  < .01 .09 ns 
Person-centered sleep onset 
latency 
- .06 .05 ns 
Person-centered sleep 
efficiency 
- .04 .14 ns 
Person-centered wake after 
sleep onset 
.02 .03 ns 
Person-centered total sleep 
time  
< - .01 < .01 ns 
Random effects 
Intercept 186.36 63.46 .003 
Person-centered wake after 
sleep onset 
< .01 < .01 ns 
Person-centered total sleep 
time 
< .01 < .01 ns 
Note: ns = non-significant
 
